Press release
Neuroendocrine Carcinoma Treatment Market Size Report 2032 | SCRI Development Innovations LLC, Suzhou Zelgen Biopharmaceuticals Co.,Ltd, Callisto Pharmaceuticals, Phanes Therapeutics, Nanjing Leads Biolabs Co.,Ltd, Hutchison Medipharma Limited, Boston Sci
Neuroendocrine Carcinoma Market
Key Takeaways from the Neuroendocrine Carcinoma Market Report
• In February 2025:- H. Lee Moffitt Cancer Center and Research Institute- Phase II Study of Pembrolizumab and Lenvatinib in Advanced Well-differentiated Neuroendocrine Tumors.
• In February 2025:- Boehringer Ingelheim:- The purpose of this study is to find a suitable dose of BI 764532 that people with advanced cancer can tolerate when taken alone. 2 different doses of BI 764532 are tested in this study. Another purpose is to check whether BI 764532 can make tumours shrink. BI 764532 is an antibody-like molecule (DLL3/CD3 bispecific) that may help the immune system fight cancer.
• In February 2025:- Harpoon Therapeutics:- This study will investigate the maximum tolerated dose, the recommended dose for expansion (RDE), safety, efficacy, and pharmacokinetics of gocatamig alone, gocatamig with Atezolizumab and gocatamig with I-DXd in participants with advanced cancers associated with expression of Delta-like Canonical Notch Ligand 3 (DLL3).
• In February 2025:- Monte Rosa Therapeutics Inc.:- This Phase 1/2, open-label, multicenter study is conducted in patients with previously treated selected solid tumors, including non-small cell lung cancer (NSCLC), small cell lung cancer (SCLC), high-grade neuroendocrine cancer of any primary site, diffuse large B-cell lymphoma (DLBCL), and tumors with L-MYC or N-MYC amplification.
• The increase in Neuroendocrine Carcinoma Market Size is a direct consequence of the increasing patient population and anticipated launch of emerging therapies in the 7MM.
• As per DelveInsight analysis, the Neuroendocrine Carcinoma Market is anticipated to witness growth at a considerable CAGR.
• The leading Neuroendocrine Carcinoma Companies such as SCRI Development Innovations LLC, Suzhou Zelgen Biopharmaceuticals Co.,Ltd, Callisto Pharmaceuticals, Phanes Therapeutics, Nanjing Leads Biolabs Co.,Ltd, Hutchison Medipharma Limited, Boston Scientific Corporation, Tarveda Therapeutics and others.
• Promising Neuroendocrine Carcinoma Therapies such as Carfilzomib, Selinexor, ZG005, Etoposide, Cisplatin, ZG006, and others.
Discover which therapies are expected to grab the Neuroendocrine Carcinoma Market Share @ Neuroendocrine Carcinoma Market Outlook- https://www.delveinsight.com/sample-request/neuroendocrine-carcinoma-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Neuroendocrine Carcinoma Overview
Neuroendocrine Carcinoma (NEC) is a rare and aggressive type of cancer that originates from neuroendocrine cells, which are specialized cells that have traits of both nerve cells and hormone-producing endocrine cells. These cells are found throughout the body, particularly in organs like the lungs, pancreas, gastrointestinal tract, and adrenal glands.
Neuroendocrine Carcinoma Epidemiology Insights
The epidemiology section of Neuroendocrine Carcinoma offers insights into both historical and current patient populations, as well as forecasted trends across seven major countries. This section aids in understanding the factors behind present and projected trends through analysis of various studies and input from key opinion leaders. Additionally, this portion of the market report provides information on the diagnosed patient pool, trends, and underlying assumptions.
Download the report to understand which factors are driving Neuroendocrine Carcinoma Epidemiology trends @ Neuroendocrine Carcinoma Epidemiological Insights- https://www.delveinsight.com/sample-request/neuroendocrine-carcinoma-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Neuroendocrine Carcinoma Drugs Market
The Neuroendocrine Carcinoma Drugs Market is expected to witness substantial growth in the coming years as more targeted therapies receive regulatory approval and enter clinical practice. Additionally, ongoing research efforts aimed at better understanding the molecular mechanisms underlying Neuroendocrine Carcinoma signaling in Neuroendocrine Carcinoma are likely to uncover new therapeutic targets and further expand treatment options for patients.
Neuroendocrine Carcinoma Treatment Market Landscape
The Neuroendocrine Carcinoma treatment market landscape has witnessed significant advancements over the past years, with targeted therapies playing a crucial role in improving outcomes for patients. Among these targeted therapies, the emergence of Neuroendocrine Carcinoma has garnered attention in the medical community, presenting both challenges and opportunities in treatment strategies.
To learn more about Neuroendocrine Carcinoma treatment guidelines, visit @ Neuroendocrine Carcinoma Treatment Market Landscape- https://www.delveinsight.com/sample-request/neuroendocrine-carcinoma-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Neuroendocrine Carcinoma Market Outlook
The report's outlook on the Neuroendocrine Carcinoma market aids in developing a comprehensive understanding of historical, current, and projected trends. This is achieved by examining the influence of existing Neuroendocrine Carcinoma therapies, unmet needs, as well as drivers, barriers, and the demand for advanced technology. This section provides detailed insights into the trends of each marketed Neuroendocrine Carcinoma drug and late-stage pipeline therapy.
Neuroendocrine Carcinoma Drugs Uptake
The drug chapter of the Neuroendocrine Carcinoma report provides a comprehensive analysis of both marketed drugs and late-stage pipeline drugs for this condition. It delves into the details of clinical trials, pharmacological actions, agreements, collaborations, approvals, patents, and advantages, and disadvantages of each drug, as well as the latest news and press releases related to Neuroendocrine Carcinoma.
Major Neuroendocrine Carcinoma Companies
SCRI Development Innovations LLC, Suzhou Zelgen Biopharmaceuticals Co.,Ltd, Callisto Pharmaceuticals, Phanes Therapeutics, Nanjing Leads Biolabs Co.,Ltd, Hutchison Medipharma Limited, Boston Scientific Corporation, Tarveda Therapeutics and others.
Learn more about the FDA-approved drugs for Neuroendocrine Carcinoma @ Drugs for Neuroendocrine Carcinoma Treatment- https://www.delveinsight.com/sample-request/neuroendocrine-carcinoma-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Scope of the Neuroendocrine Carcinoma Market Report
• Coverage- 7MM
• Neuroendocrine Carcinoma Companies- SCRI Development Innovations LLC, Suzhou Zelgen Biopharmaceuticals Co.,Ltd, Callisto Pharmaceuticals, Phanes Therapeutics, Nanjing Leads Biolabs Co.,Ltd, Hutchison Medipharma Limited, Boston Scientific Corporation, Tarveda Therapeutics and others.
• Neuroendocrine Carcinoma Therapies- Carfilzomib, Selinexor, ZG005, Etoposide, Cisplatin, ZG006, and others.
• Neuroendocrine Carcinoma Market Dynamics: Neuroendocrine Carcinoma Market Drivers and Barriers
• Neuroendocrine Carcinoma Market Access and Reimbursement, Unmet Needs and Future Perspectives
Discover more about Neuroendocrine Carcinoma Drugs in development @ Neuroendocrine Carcinoma Clinical Trials Assessment- https://www.delveinsight.com/sample-request/neuroendocrine-carcinoma-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Table of Content
1. Key Insights
2. Report Introduction
3. Neuroendocrine Carcinoma Market Overview at a Glance
4. Executive Summary of Neuroendocrine Carcinoma
5. Key Events
6. Epidemiology and Market Methodology
7. Disease Background and Overview
8. Epidemiology and Patient Population
9. Patient Journey
10. Marketed Therapies
11. Emerging Therapies
12. Neuroendocrine Carcinoma: Market Analysis
13. KOL Views
14. SWOT Analysis
15. Unmet Needs
16. Market Access
17. Appendix
18. DelveInsight Capabilities
19. Disclaimer
20. About DelveInsight
List of Top Selling Market Research Reports in 2025
Attention deficit hyperactivity disorder market- https://www.delveinsight.com/report-store/attention-deficit-hyperactivity-disorder-adhd-market
Lactose intolerance market- https://www.delveinsight.com/report-store/lactose-intolerance-market
Urea cycle disorders market- https://www.delveinsight.com/blog/urea-cycle-disorder-market
Overactive bladder syndrome market- https://www.delveinsight.com/report-store/underactive-bladder-market
Surgical energy instruments market- https://www.delveinsight.com/report-store/surgical-energy-instruments-electrosurgical-devices-market
Pipeline assessment services- https://www.delveinsight.com/consulting/pipeline-assessment-services
Total knee arthroplasty market- https://www.delveinsight.com/report-store/total-knee-arthroplasty-market
Indwelling catheters market- https://www.delveinsight.com/report-store/urinary-catheters-market
Intraocular lens market- https://www.delveinsight.com/blog/top-companies-in-the-intraocular-lens-market
Surgical robotic system market- https://www.delveinsight.com/report-store/surgical-robotic-system-market
Surgical sealant market - https://www.delveinsight.com/report-store/surgical-sealant-and-adhesives-market
Novel drug delivery devices market- https://www.delveinsight.com/report-store/novel-drug-delivery-devices
Healthcare competitive benchmarking- https://www.delveinsight.com/consulting/competitive-benchmarking-services
Surgical mask & respirator market- https://www.delveinsight.com/report-store/surgical-mask-respirator-market
Ventral hernia market- https://www.delveinsight.com/report-store/hernia-repair-devices-market
Bone growth stimulator market- https://www.delveinsight.com/report-store/bone-growth-stimulators-market
Antibody drug conjugate market- https://www.delveinsight.com/report-store/antibody-drug-conjugate-adc-market
Dyspepsia market- https://www.delveinsight.com/report-store/functional-dyspepsia-pipeline-insight
Trichotillomania market- https://www.delveinsight.com/sample-request/trichotillomania-ttm-market
Medical marijuana market- https://www.delveinsight.com/blog/medical-marijuana-market
About Us
DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.
Contact Us
Yash Bhardwaj
info@delveinsight.com
https://www.delveinsight.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Neuroendocrine Carcinoma Treatment Market Size Report 2032 | SCRI Development Innovations LLC, Suzhou Zelgen Biopharmaceuticals Co.,Ltd, Callisto Pharmaceuticals, Phanes Therapeutics, Nanjing Leads Biolabs Co.,Ltd, Hutchison Medipharma Limited, Boston Sci here
News-ID: 3894622 • Views: …
More Releases from DelveInsight Business Research LLP
Genital Warts Pipeline Insights Report 2025 | DelveInsight
DelveInsight's, "Genital Warts Pipeline Insight 2025" report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Genital Warts pipeline landscape. It covers the Genital Warts pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight and stay ahead…
Traumatic Brain Injury Pipeline Drugs Report 2025 | DelveInsight
DelveInsight's "Traumatic Brain Injury Pipeline Insight 2025" report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Tthe raumatic Brain Injury pipeline landscape. It covers the Traumatic Brain Injury pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Traumatic Brain Injury pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore…
Bone Metastasis Pipeline Assessment Report 2025 | DelveInsight
DelveInsight's, "Bone Metastases Pipeline Insight, 2025," report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Bone Metastases pipeline landscape. It covers the Bone Metastasis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Bone Metastasis pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight…
Acquired Immunodeficiency Syndrome Treatment Market Size Report 2032 | DelveInsi …
DelveInsight's "Acquired Immunodeficiency Syndrome Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Acquired Immunodeficiency Syndrome, historical and forecasted epidemiology as well as the Acquired Immunodeficiency Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
To Know in detail about the Acquired Immunodeficiency Syndrome market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Acquired Immunodeficiency Syndrome Market…
More Releases for Neuroendocrine
Neuroendocrine Carcinoma Market Massive Growth opportunity Ahead
Introduction
Neuroendocrine carcinoma (NEC) is a rare and aggressive form of cancer that arises from neuroendocrine cells, which are found throughout the body and are responsible for producing hormones. These tumors can occur in various organs, including the lungs, pancreas, liver, and gastrointestinal tract. Due to its often vague and non-specific symptoms, neuroendocrine carcinoma is frequently diagnosed at an advanced stage, making it challenging to treat effectively.
In recent years, however, there…
Rising Neuroendocrine Tumors Fuel Treatment Market Growth Driving Market Acceler …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Neuroendocrine Tumor Treatment Market Size By 2025?
The industry for treating neuroendocrine tumors has witnessed substantial growth in the previous years. The market size is projected to escalate from $2.17 billion in 2024 to $2.4 billion in 2025, with a compound annual growth rate (CAGR)…
Emerging Trends Influencing The Growth Of The Neuroendocrine Tumor Treatment Mar …
The Neuroendocrine Tumor Treatment Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
How Big Is the Neuroendocrine Tumor Treatment Market Size Expected to Be by 2034?
The market for neuroendocrine tumor treatment has seen a significant expansion in recent years. Projected to grow from a value…
Prominent Neuroendocrine Tumor Treatment Market Trend for 2025: Clinical Trials …
How Are the key drivers contributing to the expansion of the neuroendocrine tumor treatment market?
The neuroendocrine tumor treatment market is forecasted to expand due to the increasing incidence of neuroendocrine tumors. Neuroendocrine tumors, or NETs, are rare growths that begin in neuroendocrine cells, and their treatment is vital to managing the symptoms, controlling the tumor's growth, and applying radiation therapy to destroy the cancerous cells. The American Society of Clinical…
Neuroendocrine Tumor Treatment Market – Forecast to 2026
According to a new market research report published by Global Market Estimates, the Global Neuroendocrine Tumor Treatment Market is projected to grow from USD 1.8 billion in 2021 to USD 2.1 billion by 2026 at a CAGR value of 5.7% between 2021 to 2026. High prevalence of neuropsychiatric malignancy, awareness regarding early cancer diagnosis, and an increasing number of government initiatives, the neuroendocrine tumor therapy market is expected to rise…
Neuroendocrine Cancer Market: Rising Prevalence of Neuroendocrine Cancer and Gro …
The market report titled ‘Global Neuroendocrine Cancer Market - Size, Share and Forecast (2019 - 2026)’ produced by DataM Intelligence analyses the industry dynamics in this competitive space to provide a comprehensive analysis of the market opportunities.
Neuroendocrine Cancer Market Segmentation Analysis
Total Neuroendocrine Cancer Studies: 2499
By Drug Type
Everolimus
Sunitinib Malate
Lanreotide
Octreotide
Others
Sunitinib (Sutent) and Everolimus (Afinitor) are two major targeted drugs that are being used for the treatment of…
